Tsuruya Kota

論文

Immune-related adverse event detection in liver cancer patients treated with immune checkpoint inhibitors: Nationwide exploratory survey in Japan.

Impact of Atezolizumab + Bevacizumab Therapy on Health-Related Quality of Life in Patients with Advanced Hepatocellular Carcinoma.

Helicobacter pylori Eradication Therapy for Colorectal Mucosa-associated Lymphoid Tissue Lymphoma: Report of Two Cases.

An Adult Case of Benign Recurrent Intrahepatic Cholestasis Due to MYO5B Deficiency.

Abcb4-defect cholangitis mouse model with hydrophobic bile acid composition by in vivo liver-specific gene deletion

Comparative study of MAFLD as a predictor of metabolic disease treatment for NAFLD.

Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.

Ectopic Adrenocorticotropic Hormone Syndrome due to Pancreatic Neuroendocrine Carcinoma: A Case Report.

RECAM-J 2023-Validation and development of the Japanese version of RECAM for the diagnosis of drug-induced liver injury.

Low-grade Appendiceal Mucinous Neoplasm with Appendiceal Reduction and Re-expansion Over a Two-year Period: A Case Report.

共同研究・競争的資金等の研究課題

Polarity formation of human iPS cell-derived hepatocytes and development of a system to evaluate drug-induced liver injury

Construction of the new and efficient culture method of human iPS cell-derived hepatic progenitor-like cells

Characterization and expansion mechanisms of human iPS cell-derived hepatic progenitor-like cells